Priming pro-tumor neutrophils with IFNγ and TNFα could convert them to tumor-suppressing cells even in the presence of G-CSF and IL-6 by restoring the PI3K and p38 MAPK signaling pathways [203]. The gene discussed is CSF3; the disease is neoplasm.